Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome Notified -
Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET Notified -
Mùa bóng đá 2026 khởi tranh – LEPAS đồng hành cùng bạn theo đuổi đam mê với phong thái điềm tĩnh Notified -
Mavenir Powers Launch of My ENet App, Unifying Mobile, Broadband and IPTV for Guyana's ENet Subscribers Notified -
Court victory paves the way for Curium’s plans to provide targeted radioligand therapy to U.S. patients with GEP-NETs Notified -
Italpreziosi Celebrates Ducati’s 100th Anniversary with an Exclusive Gold and Silver Bullion Collection Notified -
Wood Mackenzie: Orbital Data Centres Cost Three Times More Than Terrestrial Alternatives as Global Power Demand Heads for 3,700 TWh Notified -
Japan and South Korea lead the shift in global summer travel trends, according to Holafly data Notified -
New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF Notified -